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Introduction
Infectious diarrhea is a worldwide public health problem. In many developing countries, diarrheal diseases remained a leading
cause of illness and death among infants and children. Bacterial pathogens probably cause less than 20 % of cases of acute
childhood diarrhea. Globally, Salmonel/a. Shigella and Campylobacter remain major contributors to diarrheal diseases. Some
strains of Escherichia coli, a normal inhabitant of the distal bowel, are pathogenic, causing sporadic cases of acute enteritis,
epidemic diarrhea (particularly in young infants) and traveler's diarrhea. Severe diarrhea in children has now been attributed to
enteroadherent strains of E. coli. In Malaysia, investigation for common diarrheal bacteria has not much been documented.
Numerous probiotic agents have been studied in the management of infectious diarrheal. Preliminary experimental
and clinical findings show that probiotics are emerging as an important, new therapy for preventing and treating infectious
diarrhea. Ingestion of probiotics can exert a positive influence on the health or physiology of the host. It was believed that it
could influence intestinal physiology either directly or indirectly through modulation of the endogenous ecosystem or immune
system.
Bifidobacteria, a probiotic, comprised a major group in the human and animal intestinal flora along with bacteroides and
eubacteria. They are thought to exert some of the protective effect against acute diarrhea diseases. Bifidobacteria are Gram
positive, non-acid fast, non-spore forming and non-motile organism. These organisms have been isolated from the faeces of
breast-fed infant, adult human intestine, vagina and mouth as well as in the alimentary tract of various kinds of animal. In the
large intestine, bifidobacteria produce acetic and lactic acids and is thought to inhibit the proliferation of putrefactive bacteria
such as escherichiae, clostridia and eubacteria.
In order to use bifidobacteria as an alternative to manage acute diarrhea, it is necessary to establish the strain that can survive
in the acidic conditions of the stomach. And also, the dose of the bifidobacteria that is able to reduce the growth of the
causative microorganism should also be established. Considering these reasons, the objectives of the present study are:
To isolate and characterize the major diarrheagenic pathogens from stool of acute diarrhea patients below 3 years of age
To study the dose-effect of Bifidobacterium spp. against the Salmonella spp. in simulated human colon environment
Materials and Methods
Thirty stool samples were collected from children, aged 3 years or younger, admitted to K7 ward, Pediatric Institute, Kuala
Lumpur Hospital. Stools samples were collected using sterile swabs and were placed in 5 ml Cary-Blair (Oxoid-Unipath Ltd.,
Basingtocke, Hampshire England) transport medium, and sent on wet ice to Microbiology Laboratory, Faculty of Food Science
and Biotechnology, Universiti Putra Malaysia. The specimens were surface plated as soon as possible, generally within 24 hrs,
onto eight different types of selective agar. Gram staining and morphology observation was performed according to the
standard method of Medical Laboratory Manual by Cheesbrough (1984). The carbohydrate fermentation pattern was studied
using a commercial API 20E Kit (Biolvleriux, France) for identification of Salmonella spp., E. coli, and Yersinia
enterocolitica .. Antimicrobial susceptibility tests for Salmonella were performed using Stokes disc diffusion technique (Stokes
and Ridgway, 1980) on Mueller-Hinton agar according to NCCLS recommendations (1993). Sixteen pure isolates of purified
Salmonella were sent to Institute for Medical Research (IMR) at Jalan Pahang, Kuala Lumpur, Malaysia for serological test.
The test was done by agglutination technique. PCR-based fingerprinting was carried out in volumes of25 III containing 20-30
ng of Salmonella spp. total DNA, 2.5 mM MgCl2, 5 pmol of primer, 2.5 U of Taq DNA polymerase (Promega, USA), and 250
mM each of dA TP. JCTP. dGTP and dTTP (Prornega, USA). Two probiotic bacteria used were B. infantis ATCC 27920 and
B. pseudocatanulatum F 117 and the two diarrheal bacteria used were S. enterica ser. Enteritidis S260 and S. enterica ser.
Hindmarsh 4F I. The experiments were performed as therapeutic relationship between the probiotic cultures at three different
concentrations and me diarrheagenic pathogens at maximum level. The quantitative analysis of organic acids (acetic and lactic
acid) in the sample broth was analyzed using the High Performance Liquid Chromatography (HPLC) method. The HPLC
system includes a S::II11adzu LCIOAS Liquid Chromatograph (Shimadzu, Japan), 6000A pump, U6K injector, an organic acid
analysis column tHP-87H: Bio-Rads Laboratories, Richmond, USA) and a chart recorder (Shimadzu, Japan). The oven
temperature was set at 40 ·C. The eluent used was O.OOHN Sulphuric Acid at a flow rate ofO.7 rnl/min,
Results and Discussion
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A total of 152 faecal bacterial isolates suspected as diarrhoeagenic pathogens were recovered from this study. From
biochemical tests. gram staining and morphological studies. 120 isolates were identified as E. coli and they were recovered
from all the 30 subjects. 15 isolates of Salmonella spp were identified and obtained from 4 subjects. whilst 8 isolates identified
as Yersinia cnterocolitica and Proteus spp were recovered from 2 subjects. As E. coli is among the most common bacteria in
the normal flora of the human intestine besides the other pathogenic strains and consequently Salmonella spp. was the highest
exogenous species isolated and therefore, have been chosen for further study. All the 15 isolates of Salmonella spp. were
grouped into 3 serovars, They were 5 isolates of S. enteritica serovar Akanji isolated from Isubject, 7 isolates of S. enteritica
serovar Hindmarsh isolated from 2 subjects and 3 isolates of S. enteritica serovar Richmond isolated from I subject. The
antibiotic susceptibility test showed that all the Salmonella spp. isolates were highly susceptible to amoxicillin, ampicillin,
carbenicillin. cefuroxime, ceftaxidime, cephalotin, chloramphenicol, ciprofloxacin, nalidixic acid, and tetracycline, but mildly
susceptible to gentamycin, kanamycin, streptomycin, and penicillin. All the isolates were resistant to bacitracin and
erythromycin, Both of the control strains were highly susceptible to ceftaxidime, mildly susceptible to cephalotin, cefuroxime,
and gentamycin and resistant to all others antibiotic excluding kanamycin and nalidixic acid. S. enteritidis S260 was resistant
to kanamycin but susceptible to nalidixic acid, while S. typhimurium S974 was mildly susceptible to kanamycin but resistant to
nalidixic acid. Ten oligonucleotide decamers were tested for their ability to generate RAPD markers from genomic DNAs of a
subset of 4 Salmonella strains. Seven primers gave either non-reproducible patterns or gave very poor amplification. Primer
P3, P9 and PlO yielded clear and reproducible patterns and were chosen for further analysis. To obtain a comprehensive result
of the intraspecific relationships between all the strains analyzed, the data from RAPD-PCR patterns obtained with the three
primers were combined in a single dendrogram. Two main clusters were observed. Cluster I comprised 12 strains and cluster 2
contained 3 strains.
In non-control pH experiment, growth of Salmonella spp. was inhibited by proliferation of Bifidobacterium spp. in all the
combinations and dosages. The minimum viable count of both S. enterica ser. Hindmarsh 4FI and S. enterica ser. Enteritis
S260 after cultivated with B. pseudocatanulatum FII were 107 and 10K, respectively for all dosages. When B. in/an/is ATCC
27920 was used as bio-therapeutic agent, the minimum viable count of both Salmonella strains were 108 at dose I and dose 2
but it was 107 at dose 3. However, at different dosages of bifidobacteria, the minimum viable count has been reached at
different time interval.
This study as well, indicates that higher concentration of bifidobacteria need longer time to inhibit the salmonella to the
minimum level. Moreover, the duration on achieving of maximum inhibition was depends on tested and target strains. It seems
like B. pseudocatanulatum FI17 more effective to inhibit S. enterica ser. Enteritis S260 while B. in/antis ATCC 27920 more
effective to inhibit S. enterica ser. Hindmarsh 4FI in term of time required. From the observation, the inhibition activities were
absolutely effect by decreasing of pH values. Generally, at certain time interval the pH would be increased back and the viable
count ofbifidobacteria would be decreased.
Changes of pH values were noticed in the entire combinations and dosages. The pH values were decreased with
increasing of time. The minimum pH associated with all dosages of B. pseudocatanulatum F 117 were depends on resident
strain but not for B. in/antis ATCC 27920. In cultivation with S. enterica ser. Akanji 3Cl as a resident strain, the minimum pH
that has been achieved was 4.0, while if S. enterica ser. Enteritidis S260 as a resident strain, the minimum pH was 4.2. In
contrast, the minimum pH associated with all dosages of B. in/an/is ATeC 27920 was 4.6 when inoculated to both resident
strains.
When the pH of the cultivation medium was control all through the experiment at pH 5.S - 6.0, there were decreased in viable
count of Salmonella spp. as well. The trend of decreasing was almost the same as the non-control pH but they were I log and 2
logs higher when cultured with B. pseudocatanulatum FI17 and B. in/an/is ATCC 27920 respectively. Moreover, the times
they take to inhibit the Salmonella spp. to the minimum viable count were longer. This was likely disagreed with the fact that
the decreasing on pH values of the medium solely attributed inhibition activity of bifidobacteria. Furthermore, there was no
declining ofbifidobacteria viable counts at the end of the experiments were observed.
In non-control pH batch, production of acetate and lactate by the Bifidobacterium strains was observed. Roughly, it
looks like the production of those organic acids was higher when the initial count of bifidobacteria was lower . B.
pseudocatanulatum F 117 was produced more acetate and lactate when cultivated with S. enterica ser. Enteritidis compared to
S260 S. enterica ser. Hindmarsh 4FI. While B. infantis ATCC 27920 was produced more lactate but less acetate when
cultivated with S. enterica ser. Hindmarsh 4FI compared to S. enterica ser. Enteritidis S260. In overall, B. pseudocatanulatum
F 117 was produced more organic acid compared to B. in/antis ATCC 27920.
The duration to produced the maximum concentration of acetate was not depends on the dosage of Bifidobacterium
species. All the combination and dosages were produced the maximum concentration of acetate in 48 hrs except B. infantis
ATee 27920 versus S. enterica ser. Enteritidis, which the duration was 54 hrs. However. lactate production was depends on
the dosage of bifidobacteria and the target strain. The results demonstrated that dose 2 have the minimum duration time in
producing the maximum concentration of lactate. Dose I and 3 has the same duration time except B. in/an/is ATCC 27920
versus S. enterica ser. Hindmarsh 4FI where dose I have longer duration time compared to dose 3. The concentrations of
organic acids were generally decreased at the end point of the experiment.
Conclusions
This study was designed to investigate the inhibitory activity and dose effects of selected probiotic microorganisms against
common diarrheal bacteria associated with acute diarrhea in children under 3 years old. who where admitted to Pediatric
Institute, Kuala Lumpur Hospital. The first part of the study involved the isolation and identification of diarrheal bacteria from
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stool sample of infected children. The results suggest that Salmonella spp. was one of the etiologies as they were the main
pathogen isolated from children with acute diarrhea at Pediatric Institute, Kuala Lumpur Hospital.
In the second part of the study, the survival of bifidobaeteria in the human stomach at the pH after meal compared to the pH
before meal (fasted state) was evaluated. The results demonstrated that those probiotic could tolerate in both stomach acidity,
however the tolerance was better in the pH range after meal consumption. The survival counts of both conditions have been
used as the dosage of these probiotic in dose effects study.
Benefits from the study
An alternative technique in the prevention and treatment of gastro-enteritis. The technique exploits GIT microbial relationship.
And develop a technique to reduce the incidence of acute diarrhea and rotavirus shedding in infants and children. So, infant
and children diarrhea. which has been a major cause of mortality can be reduced
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